Although the science and intellectual property are the prime drivers of value, the quality of the supporting documentation is an increasingly important consideration.
A new paradigm shift has the ability to transform outsourced clinical research and give rise to a new kind of contract research organization, the digital CRO.
After decades of dreaming the drug developer’s impossible dream, scientists are finally reporting progress in making drugs that target the the hundreds of thousands of proteins that many scientists considered to be “undruggable".
Scientists reported the first evidence that eating blueberries, strawberries, and acai berries may help the aging brain stay healthy. Berries, and possibly walnuts, activate the brain’s natural “housekeeper” mechanism, which cleans up and recycles toxic proteins linked to age-related memory loss.
The World Health Organization has granted prequalification status to Pfizer Inc.'s children's pneumococcal vaccine, Prevenar 13, paving the way for United Nations agencies and governments to start ordering the product.
A U.S. government study has uncovered a family of mouse viruses in some people with chronic fatigue syndrome, raising still more questions about whether an infection may play a role in the complicated illness.
A federal judge temporarily blocked government rules expanding stem cell research, a blow to the Obama administration that could stall potentially lifesaving research.
Mirus Bio now offers a new transfection kit ideal for biotherapeutic protein production in large pharma and biotech settings. The TransIT-PRO Kit will decrease time to produce usable protein by maximizing target protein yields through transient transfection.
G-Biosciences’ Pearl IgG Purification Kit allows for the one step purification of IgG antibodies from serum. The kit is supplied with Pearl IgG Purification Resin which binds non-IgG proteins, but allows IgG molecules to pass through to a physiological buffer.
SAFC and Novozymes Biopharma DK A/S announced a 10-year extension of their joint agreement under which SAFC retains exclusive marketing and distribution rights for Novozymes Biopharma's LONGR³IGF-I growth factor for industrial cell culture applications.
Precision Antibody announced that the EPA has selected it to develop monoclonal antibodies to two species of Cryptosporidium, an intestinal parasite that has emerged over the past 20 years as one of the most common causes of waterborne illness in the United States.
Mutations in a single gene can cause several types of developmental brain abnormalities that experts have traditionally considered different disorders.
Researchers have purified, for the first time, the protein produced by the breast cancer susceptibility gene BRCA2 and used it to study the oncogene's role in DNA repair.
AVI BioPharma, Inc. announced preclinical data demonstrating that AVI-6002 and AVI-6003, the respective lead therapeutic candidates against Ebola and Marburg viruses provide post exposure efficacy in non-human primates.
Curaxis Pharmaceutical Corp. announced an update on the company's clinical development plans for Memryte, its candidate to treat mild-to-moderate Alzheimer's disease.